Literature DB >> 19367664

Cytoprotective effect of lignans from Forsythia suspensa against peroxynitrite-induced LLC-PK1 cell damage.

Xiang Lan Piao1, Eun Jung Cho, Eun June Cho, Moon Hee Jang, Jian Cui.   

Abstract

There is mounting evidence that peroxynitrite (ONOO(-)) is closely related to the pathogenesis of various diseases. As a pharmacological strategy aimed at preventing ONOO(-)-mediated toxicity, the protective activity of Forsythia suspensa (Thunb.) Vahl (Oleaceae) against ONOO(-)-induced cellular damage was investigated and its active components identified. After bioactivity-guided fractionation of its methylene chloride fraction, two tetrahydrofurofuran lignans were isolated, namely phillygenin and 8-hydroxypinoresinol. The protective effects of these lignans against ONOO(-)-induced cell death were evaluated using renal epithelial cell LLC-PK1. Phillygenin and 8-hydroxypinoresinol significantly reduced the cell injury by 3-morpholinosydnonimine (SIN-1), a ONOO(-) generator. The hydroxy substituents on the phenyl moieties may contribute to the antioxidant activities of these lignans. These results suggest that phillygenin and 8-hydroxypinoresinol may be useful for the therapeutic or preventive applications in treating ONOO(-)-related diseases. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367664     DOI: 10.1002/ptr.2834

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  9 in total

1.  Pharmacokinetic study of unbound forsythiaside in rat blood and bile by microdialysis coupled with HPLC method.

Authors:  Yang Chu; Xiangyang Wang; Jiahua Guo; Wei Li; Xiaohui Ma; Yonghong Zhu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-09       Impact factor: 2.441

2.  Determination of phillygenin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies.

Authors:  Liang-hong Ye; Yun-xia Li; Cheng Peng; Xiao-hong Gong; Xin-guang Zheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-07       Impact factor: 2.441

3.  Chemistry and pharmacology of the herb pair Flos Lonicerae japonicae-Forsythiae fructus.

Authors:  Yi-Ping Guo; Li-Gen Lin; Yi-Tao Wang
Journal:  Chin Med       Date:  2015-07-02       Impact factor: 5.455

4.  Forsythia suspensa Extract Has the Potential to Substitute Antibiotic in Broiler Chicken.

Authors:  X Han; X S Piao; H Y Zhang; P F Li; J Q Yi; Q Zhang; P Li
Journal:  Asian-Australas J Anim Sci       Date:  2012-04       Impact factor: 2.509

5.  Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse.

Authors:  Wei Song; Junjun Wu; Longjiang Yu; Zhihong Peng
Journal:  Biomed Res Int       Date:  2018-08-23       Impact factor: 3.411

Review 6.  Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics.

Authors:  Zhanglu Dong; Xianyuan Lu; Xueli Tong; Yaqian Dong; Lan Tang; Menghua Liu
Journal:  Molecules       Date:  2017-09-04       Impact factor: 4.411

7.  Effects of Forsythia Suspense Extract as an Antibiotics Substitute on Growth Performance, Nutrient Digestibility, Serum Antioxidant Capacity, Fecal Escherichia coli Concentration and Intestinal Morphology of Weaned Piglets.

Authors:  Shenfei Long; Li Liu; Sujie Liu; Shad Mahfuz; Xiangshu Piao
Journal:  Animals (Basel)       Date:  2019-09-26       Impact factor: 2.752

8.  Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway.

Authors:  Jiantao He; Wei Wei; Qingbo Yang; Yiling Wang
Journal:  Med Sci Monit       Date:  2019-01-25

9.  Forsythia suspensa extract enhances performance via the improvement of nutrient digestibility, antioxidant status, anti-inflammatory function, and gut morphology in broilers.

Authors:  S F Long; T F He; D Wu; M Yang; X S Piao
Journal:  Poult Sci       Date:  2020-06-17       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.